{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:35:10Z","timestamp":1761561310481,"version":"3.37.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s11926-009-0006-4","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T13:08:22Z","timestamp":1233666502000},"page":"36-40","source":"Crossref","is-referenced-by-count":18,"title":["Aspirin and acetaminophen: Should they be available over the counter?"],"prefix":"10.1007","volume":"11","author":[{"given":"Kay","family":"Brune","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Hinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Otterness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,4]]},"reference":[{"key":"6_CR1","first-page":"1338","volume":"27","author":"P.E. Lipsky","year":"2000","unstructured":"Lipsky PE, Abramson SB, Breedveld FC, et al.: Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice. J Rheumatol 2000, 27:1338\u20131340.","journal-title":"J Rheumatol"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(07)61909-6","volume":"370","author":"V. Strand","year":"2007","unstructured":"Strand V: Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin? Lancet 2007, 370:2138\u20132151.","journal-title":"Lancet"},{"key":"6_CR3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tips.2008.06.004","volume":"29","author":"B. Hinz","year":"2008","unstructured":"Hinz B, Brune K: Can drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacology. Trends Pharmacol Sci 2008, 29:391\u2013397.","journal-title":"Trends Pharmacol Sci"},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","volume":"332","author":"P.M. Kearney","year":"2006","unstructured":"Kearney PM, Baigent C, Godwin J, et al.: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006, 332:1302\u20131308.","journal-title":"BMJ"},{"key":"6_CR5","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"R.S. Bresalier","year":"2005","unstructured":"Bresalier RS, Sandler RS, Quan H, et al.: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005, 352:1092\u20131102.","journal-title":"N Engl J Med"},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","volume":"352","author":"S.D. Solomon","year":"2005","unstructured":"Solomon SD, McMurray JJ, Pfeffer MA, et al.: Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005, 352:1071\u20131080.","journal-title":"N Engl J Med"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.330.7504.1366","volume":"330","author":"J. Hippisley-Cox","year":"2005","unstructured":"Hippisley-Cox J, Coupland C: Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005, 330:1366.","journal-title":"BMJ"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1517\/14656566.9.8.1311","volume":"9","author":"M. Farooq","year":"2008","unstructured":"Farooq M, Haq I, Qureshi AS: Cardiovascular risks of COX inhibition: current perspectives. Expert Opin Pharmacother 2008, 9:1311\u20131319.","journal-title":"Expert Opin Pharmacother"},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1096\/fj.03-0645rev","volume":"18","author":"T.D. Warner","year":"2004","unstructured":"Warner TD, Mitchell JA: Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 2004, 18:790\u2013804.","journal-title":"FASEB J"},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.328.7437.434","volume":"328","author":"C. Jenkins","year":"2004","unstructured":"Jenkins C, Costello J, Hodge L: Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004, 328:434.","journal-title":"BMJ"},{"key":"6_CR11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2036.2004.02092.x","volume":"20","author":"J.H. Rubenstein","year":"2004","unstructured":"Rubenstein JH, Laine L: Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2004, 20:373\u2013380.","journal-title":"Aliment Pharmacol Ther"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","volume":"353","author":"C. Patrono","year":"2005","unstructured":"Patrono C, Garc\u00eda Rodr\u00edguez LA, Landolfi R, Baigent C: Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005, 353:2373\u20132383.","journal-title":"N Engl J Med"},{"key":"6_CR13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-3565(25)03631-6","volume":"97","author":"B.B. Brodie","year":"1949","unstructured":"Brodie BB, Axelrod J: The fate of acetophenetidin in man and methods for the estimation of acetophenetidin and its metabolites in biological material. J Pharmacol Exp Ther 1949, 97:58\u201367.","journal-title":"J Pharmacol Exp Ther"},{"key":"6_CR14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","volume":"22","author":"B. Hinz","year":"2008","unstructured":"Hinz B, Cheremina O, Brune K: Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 2008, 22:383\u2013390.","journal-title":"FASEB J"},{"key":"6_CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11926-008-0009-6","volume":"10","author":"C.R. Scanzello","year":"2008","unstructured":"Scanzello CR, Moskowitz NK, Gibofsky A: The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis. Curr Rheumatol Rep 2008, 10:49\u201356.","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl5","key":"6_CR16","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1086\/317520","volume":"31","author":"R.M. Botting","year":"2000","unstructured":"Botting RM: Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis 2000, 31(Suppl 5):S202\u2013S210.","journal-title":"Clin Infect Dis"},{"key":"6_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.105.085431","volume":"315","author":"B. Kis","year":"2005","unstructured":"Kis B, Snipes JA, Busija DW: Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J Pharmacol Exp Ther 2005, 315:1\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"6_CR18","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1572-0241.2008.01811.x","volume":"103","author":"E. Rahme","year":"2008","unstructured":"Rahme E, Barkun A, Nedjar H, et al.: Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 2008, 103:872\u2013882.","journal-title":"Am J Gastroenterol"},{"key":"6_CR19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1034\/j.1399-6576.2000.440113.x","volume":"44","author":"T.T. Niemi","year":"2000","unstructured":"Niemi TT, Backman JT, Syrj\u00e4l\u00e4 MT, et al.: Platelet dysfunction after intravenous ketorolac or propacetamol. Acta Anaesthesiol Scand 2000, 44:69\u201374.","journal-title":"Acta Anaesthesiol Scand"},{"key":"6_CR20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1081\/JDI-65428","volume":"27","author":"G. Mour","year":"2005","unstructured":"Mour G, Feinfeld DA, Caraccio T, McGuigan M: Acute renal dysfunction in acetaminophen poisoning. Ren Fail 2005, 27:381\u2013383.","journal-title":"Ren Fail"},{"key":"6_CR21","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.105.595793","volume":"113","author":"A.T. Chan","year":"2006","unstructured":"Chan AT, Manson JE, Albert CM, et al.: Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 2006, 113:1578\u20131587.","journal-title":"Circulation"},{"key":"6_CR22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.HYP.0000177437.07240.70","volume":"46","author":"J.P. Forman","year":"2005","unstructured":"Forman JP, Stampfer MJ, Curhan GC: Non-narcotic analgesic dose and risk of incident hypertension in US women. Hypertension 2005, 46:500\u2013507.","journal-title":"Hypertension"},{"key":"6_CR23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.296.1.87","volume":"296","author":"P.B. Watkins","year":"2006","unstructured":"Watkins PB, Kaplowitz N, Slattery JT, et al.: Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006, 296:87\u201393.","journal-title":"JAMA"},{"key":"6_CR24","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00365520510023846","volume":"40","author":"E. Bj\u00f6rnsson","year":"2005","unstructured":"Bj\u00f6rnsson E, Jerlstad P, Bergqvist A, Olsson R: Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 2005, 40:1095\u20131101.","journal-title":"Scand J Gastroenterol"},{"key":"6_CR25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000111032","volume":"75","author":"S. Kr\u00e4henbuhl","year":"2007","unstructured":"Kr\u00e4henbuhl S, Brauchli Y, Kummer O, et al.: Acute liver failure in two patients with regular alcohol consumption ingesting paracetamol at therapeutic dosage. Digestion 2007, 75:232\u2013237.","journal-title":"Digestion"},{"key":"6_CR26","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/adc.2005.076836","volume":"91","author":"S.B. Mahadevan","year":"2006","unstructured":"Mahadevan SB, McKiernan PJ, Davies P, Kelly DA: Paracetamol induced hepatotoxicity. Arch Dis Child 2006, 91:598\u2013603.","journal-title":"Arch Dis Child"},{"key":"6_CR27","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpeds.2005.12.051","volume":"148","author":"R.H. Squires Jr","year":"2006","unstructured":"Squires RH Jr, Shneider BL, Bucuvalas J, et al.: Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006, 148:652\u2013658.","journal-title":"J Pediatr"},{"key":"6_CR28","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/hep.21926","volume":"46","author":"W.M. Lee","year":"2007","unstructured":"Lee WM: Acetaminophen toxicity: changing perceptions on a social\/medical issue. Hepatology 2007, 46:966\u2013970.","journal-title":"Hepatology"},{"key":"6_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJM199107113250203","volume":"325","author":"J.D. Bradley","year":"1991","unstructured":"Bradley JD, Brandt KD, Katz BP, et al.: Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991, 325:87\u201391.","journal-title":"N Engl J Med"},{"key":"6_CR30","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/1529-0131(200107)44:7<1587::AID-ART282>3.0.CO;2-X","volume":"44","author":"T. Pincus","year":"2001","unstructured":"Pincus T, Koch GG, Sokka T, et al.: A randomized, doubleblind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001, 44:1587\u20131598.","journal-title":"Arthritis Rheum"},{"key":"6_CR31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archinte.163.2.169","volume":"163","author":"J.P. Case","year":"2003","unstructured":"Case JP, Baliunas AJ, Block JA: Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med 2003, 163:169\u2013178.","journal-title":"Arch Intern Med"},{"key":"6_CR32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/ard.2003.020313","volume":"63","author":"T. Pincus","year":"2004","unstructured":"Pincus T, Koch G, Lei H, et al.: Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Ann Rheum Dis 2004, 63:931\u2013939.","journal-title":"Ann Rheum Dis"},{"key":"6_CR33","first-page":"CD004257","volume":"1","author":"T.E. Towheed","year":"2006","unstructured":"Towheed TE, Maxwell L, Judd MG, et al.: Acetaminophen for osteoarthritis. Cochrane Database System Rev 2006, 1:CD004257.","journal-title":"Cochrane Database System Rev"},{"key":"6_CR34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","volume":"116","author":"T. Grosser","year":"2006","unstructured":"Grosser T, Fries S, FitzGerald GA: Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 2006, 116:4\u201315.","journal-title":"J Clin Invest"},{"key":"6_CR35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1185\/030079907X162656","volume":"23","author":"A. Lanas","year":"2007","unstructured":"Lanas A, Scheiman J: Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin 2007, 23:163\u2013173.","journal-title":"Curr Med Res Opin"},{"key":"6_CR36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/clpt.1993.55","volume":"53","author":"D.W. Kaufman","year":"1993","unstructured":"Kaufman DW, Kelly JP, Sheehan JE, et al.: Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993, 53:485\u2013494.","journal-title":"Clin Pharmacol Ther"},{"key":"6_CR37","doi-asserted-by":"crossref","unstructured":"Fosb\u00f8l E, Gislason G, Jacobsen S, et al.: Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin Pharmacol Ther 2008 (in press).","DOI":"10.1038\/clpt.2008.204"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0006-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-009-0006-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0006-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:45:54Z","timestamp":1738925154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-009-0006-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s11926-009-0006-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"type":"print","value":"1523-3774"},{"type":"electronic","value":"1534-6307"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}